Skip to main content
Journal cover image

Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.

Publication ,  Journal Article
Birnkrant, DJ; Bushby, K; Bann, CM; Alman, BA; Apkon, SD; Blackwell, A; Case, LE; Cripe, L; Hadjiyannakis, S; Olson, AK; Sheehan, DW; Bolen, J ...
Published in: Lancet Neurol
April 2018

A coordinated, multidisciplinary approach to care is essential for optimum management of the primary manifestations and secondary complications of Duchenne muscular dystrophy (DMD). Contemporary care has been shaped by the availability of more sensitive diagnostic techniques and the earlier use of therapeutic interventions, which have the potential to improve patients' duration and quality of life. In part 2 of this update of the DMD care considerations, we present the latest recommendations for respiratory, cardiac, bone health and osteoporosis, and orthopaedic and surgical management for boys and men with DMD. Additionally, we provide guidance on cardiac management for female carriers of a disease-causing mutation. The new care considerations acknowledge the effects of long-term glucocorticoid use on the natural history of DMD, and the need for care guidance across the lifespan as patients live longer. The management of DMD looks set to change substantially as new genetic and molecular therapies become available.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Lancet Neurol

DOI

EISSN

1474-4465

Publication Date

April 2018

Volume

17

Issue

4

Start / End Page

347 / 361

Location

England

Related Subject Headings

  • Respiratory System
  • Quality of Life
  • Neurology & Neurosurgery
  • Muscular Dystrophy, Duchenne
  • Humans
  • Cardiovascular System
  • Bone and Bones
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Birnkrant, D. J., Bushby, K., Bann, C. M., Alman, B. A., Apkon, S. D., Blackwell, A., … DMD Care Considerations Working Group, . (2018). Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol, 17(4), 347–361. https://doi.org/10.1016/S1474-4422(18)30025-5
Birnkrant, David J., Katharine Bushby, Carla M. Bann, Benjamin A. Alman, Susan D. Apkon, Angela Blackwell, Laura E. Case, et al. “Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.Lancet Neurol 17, no. 4 (April 2018): 347–61. https://doi.org/10.1016/S1474-4422(18)30025-5.
Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018 Apr;17(4):347–61.
Birnkrant, David J., et al. “Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.Lancet Neurol, vol. 17, no. 4, Apr. 2018, pp. 347–61. Pubmed, doi:10.1016/S1474-4422(18)30025-5.
Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, Case LE, Cripe L, Hadjiyannakis S, Olson AK, Sheehan DW, Bolen J, Weber DR, Ward LM, DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018 Apr;17(4):347–361.
Journal cover image

Published In

Lancet Neurol

DOI

EISSN

1474-4465

Publication Date

April 2018

Volume

17

Issue

4

Start / End Page

347 / 361

Location

England

Related Subject Headings

  • Respiratory System
  • Quality of Life
  • Neurology & Neurosurgery
  • Muscular Dystrophy, Duchenne
  • Humans
  • Cardiovascular System
  • Bone and Bones
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1109 Neurosciences